L01XC07 bevacizumab
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS in ATC
L01XC Monoclonal antibodies, antineoplastic
L01XC07 bevacizumab
Medicines by ATC code L01XC07 bevacizumab
- Abevmy Patient leaflet Summary of medicine characteristics
- Oyavas Patient leaflet Summary of medicine characteristics
- Alymsys Patient leaflet Summary of medicine characteristics
- Equidacent Patient leaflet Summary of medicine characteristics
- Zirabev Patient leaflet Summary of medicine characteristics
- Aybintio Patient leaflet Summary of medicine characteristics
- Onbevzi Patient leaflet Summary of medicine characteristics
- Avastin Patient leaflet Summary of medicine characteristics
- Mvasi Patient leaflet Summary of medicine characteristics
- Lextemy Patient leaflet Summary of medicine characteristics
Other names of the ATC group
- Czech: L01XC07 BEVACIZUMAB
- French: L01XC07 bévacizumab
- German: L01XC07 Bevacizumab
- Spanish: L01XC07 BEVACIZUMAB
- German: L01XC07 Bevacizumab
- Polish: L01XC07 BEVACIZUMAB
- Turkish: L01XC07 bevacizumab